Korro Bio, Inc. (KRRO): Shareholders' Equity
$51.44M
As of 2025-12-31
$103.23M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $51.44M | -67.9% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $160.41M | -5.6% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $169.91M | n/m | 2025-03-18, Balance as of period end |
| 2022-12-31 | -$99.03M | n/c | 2024-03-26, Balance as of period end |
| 2021-12-31 | $130.82M | -32.0% | 2023-03-10, Balance as of period end |
| 2020-12-31 | $192.49M | +15.0% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $167.36M | n/m | 2021-03-29, Balance as of period end |
| 2018-12-31 | -$48.28M | n/m | 2020-03-26, Balance as of period end |
| 2017-12-31 | -$29.64M | n/a | 2020-03-26, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $51.44M | -67.9% |
| Immunome Inc. (IMNM) | 2025-12-31 | $634.34M | +250.1% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $136.31M | +159.7% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $130.66M | +91.5% |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | $581.76M | -22.9% |
| Adagene Inc. (ADAG) | 2025-12-31 | $35.35M | -30.0% |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | $26.50M | -53.7% |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $103.08M | -33.7% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $43.03M | +8.7% |
Compare KRRO, IMNM, WHWK, OVID side by side · Screen every company in Pharmaceutical Preparations ↗